Indeed, systemic increases in PTEN activity could carry significant risks, including broad immune dysregulation or immunosuppression, disruption of metabolic homeostasis [47], as well as adverse effects on neural development and synaptic function, such as microcephaly, decreased synaptic density, and neuronal dysfunction [48,49]. The gene discussed is PTEN; the disease is microcephaly.